HFE C282Y homozygotes have reduced low-density lipoprotein cholesterol: the Atherosclerosis Risk in Communities (ARIC) Study

Atherosclerosis Risk ◽

Association of Small Dense Low-Density Lipoprotein Cholesterol and Lipoprotein-Associated Phospholipase A2 with Carotid Plaque Characteristics in the Atherosclerosis Risk in Communities Study*

Journal of Clinical Lipidology ◽

10.1016/j.jacl.2014.02.042 ◽

2014 ◽

Vol 8 (3) ◽

pp. 319-321

Author(s):

Yashashwi Pokharel ◽

Wensheng Sun ◽

Salim S. Virani ◽

Vijay Nambi ◽

Peter H. Jones ◽

...

Keyword(s):

Phospholipase A2 ◽

Carotid Plaque ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Lipoprotein Cholesterol ◽

Low Density ◽

Atherosclerosis Risk

Association of High-Density Lipoprotein Cholesterol With Coronary Heart Disease Risk Across Categories of Low-Density Lipoprotein Cholesterol: The Atherosclerosis Risk in Communities Study

The American Journal of the Medical Sciences ◽

10.1097/maj.0b013e3181f97e4a ◽

2011 ◽

Vol 341 (3) ◽

pp. 173-180 ◽

Cited By ~ 9

Author(s):

Paul Muntner ◽

Fleur Lee ◽

Brad C. Astor

Keyword(s):

Coronary Heart Disease ◽

Disease Risk ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Lipoprotein Cholesterol ◽

Low Density ◽

Atherosclerosis Risk ◽

Heart Disease Risk

ASSOCIATION OF LOW-DENSITY LIPOPROTEIN TRIGLYCERIDES (LDL-TG) AND REMNANT-LIKE PROTEIN CHOLESTEROL (RLP-C) WITH CARDIOVASCULAR EVENTS IN THE ELDERLY: THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(20)32523-7 ◽

2020 ◽

Vol 75 (11) ◽

pp. 1896

Author(s):

Aliza Hussain ◽

Wensheng Sun ◽

Elizabeth Selvin ◽

Vijay Nambi ◽

Josef Coresh ◽

...

Keyword(s):

Cardiovascular Events ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

The Elderly ◽

Low Density ◽

Atherosclerosis Risk ◽

Low-density lipoprotein and high-density lipoprotein cholesterol levels in relation to genetic polymorphisms and menopausal status: The Atherosclerosis Risk in Communities (ARIC) Study

Atherosclerosis ◽

10.1016/j.atherosclerosis.2007.12.045 ◽

2008 ◽

Vol 200 (2) ◽

pp. 322-328 ◽

Cited By ~ 12

Author(s):

Alanna M. Chamberlain ◽

Aaron R. Folsom ◽

Pamela J. Schreiner ◽

Eric Boerwinkle ◽

Christie M. Ballantyne

Keyword(s):

High Density Lipoprotein ◽

High Density Lipoprotein Cholesterol ◽

Low Density Lipoprotein ◽

Menopausal Status ◽

Density Lipoprotein ◽

Low Density ◽

Cholesterol Levels ◽

Atherosclerosis Risk ◽

Relationship between low-density lipoprotein subclasses and asymptomatic atherosclerosis in subjects from the atherosclerosis risk in communities (ARIC) Study

Biomarkers ◽

10.1080/13547500410001720758 ◽

2004 ◽

Vol 9 (2) ◽

pp. 190-202 ◽

Cited By ~ 12

Author(s):

D. Michael Hallman ◽

Spencer A. Brown ◽

Christie M. Ballantyne ◽

A. Richey Sharrett ◽

Eric Boerwinkle

Keyword(s):

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Low Density ◽

Lipoprotein Subclasses ◽

Atherosclerosis Risk ◽

928 The more low-density lipoprotein cholesterol decreases by statin, the more fibrous component increases in a coronary atherosclerotic plaque: a prospective randomized study with intravascular ultrasound-radiofrequency analysis

European Heart Journal ◽

10.1016/s0195-668x(03)94220-5 ◽

2003 ◽

Vol 24 (5) ◽

pp. 153

Author(s):

N KOMIYAMA

Keyword(s):

Intravascular Ultrasound ◽

Atherosclerotic Plaque ◽

Low Density Lipoprotein ◽

Randomized Study ◽

Density Lipoprotein ◽

Lipoprotein Cholesterol ◽

Prospective Randomized Study ◽

Low Density ◽

Coronary Atherosclerotic Plaque

Empagliflozin Improves Kidney Outcomes Irrespective of Control of Blood Pressure, Low-Density Lipoprotein Cholesterol and HbA1c

10.1055/s-0039-1688342 ◽

2019 ◽

Author(s):

C Wanner ◽

M Cooper ◽

S Inzucchi ◽

B Zinman ◽

I Zwiener ◽

...

Keyword(s):

Blood Pressure ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Lipoprotein Cholesterol ◽

Low Density ◽

Low Density Lipoprotein Cholesterol and Coronary Heart Disease – Lower is Better

European Cardiology Review ◽

10.15420/ecr.2005.1c ◽

2005 ◽

Vol 1 (1) ◽

pp. 1

Author(s):

Professor Dr M Breuer Hans-Willi ◽

Keyword(s):

Coronary Heart Disease ◽

Heart Disease ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Lipoprotein Cholesterol ◽

Low Density ◽

03 - A dietary exchange model to study inter-individual variation in serum low-density lipoprotein cholesterol response to dietary sa

10.26226/morressier.5beaf069e668b9000b9ad79e ◽

2018 ◽

Author(s):

rona antoni ◽

Laury Sellem ◽

Athanasios Koutsos

Keyword(s):

Individual Variation ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Exchange Model ◽

Lipoprotein Cholesterol ◽

Low Density ◽

Faculty Opinions recommendation of Cardiovascular event reduction and adverse events among subjects attaining low-density lipoprotein cholesterol <50 mg/dl with rosuvastatin. The JUPITER trial (Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin).

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.10173956.10958055 ◽

2011 ◽

Author(s):

Wilbert Aronow

Keyword(s):

Adverse Events ◽

Cardiovascular Event ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Lipoprotein Cholesterol ◽

Low Density ◽

Intervention Trial ◽